BN 80933

Drug Profile

BN 80933

Alternative Names: BIM 80933; BN80933

Latest Information Update: 30 Nov 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Institut Henri Beaufour-Ipsen
  • Class Anti-ischaemics; Antiparkinsonians; Neuroprotectants; Pyrazines; Small molecules; Thiophenes
  • Mechanism of Action Free radical scavengers; Lipid peroxidation inhibitors; Nitric oxide synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cerebral ischaemia; Neurological disorders

Most Recent Events

  • 22 Oct 2003 A preclinical study has been added to the Neurological disorders pharmacodynamics section
  • 05 Jun 2003 Beaufour-Ipsen is now called Ipsen
  • 21 Dec 2001 BIM 80933 is available for licensing
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top